Publications
Abstract
Fingerprinting tolerance in Renal Transplantation
7th Trends in Immunosuppression, Berlin, Germany, February, 2006 (Abstract #A21)
Sagoo P, Hernandez-Fuentes M, Jimenez-Vera E, Rovis F, Hilton R, Warrens A, Lechler RI
Sagoo P, Hernandez-Fuentes M, Jimenez-Vera E, Rovis F, Hilton R, Warrens A, Lechler RI (2006). Fingerprinting tolerance in Renal Transplantation. (Abstract #A21) 7th Trends in Immunosuppression, Berlin, Germany, February, 2006.
Advances in Immune Monitoring in Renal Transplantation
World Transplant Congress, Boston, MA, July 22-27, 2006 (Abstract #1888)
Sagoo P, Hernandez-Fuentes MP, Jimenez E, Perucha E, Warrens A, Lechler RI, Flavia R, Stevenson S, Milton R
Sagoo P, Hernandez-Fuentes MP, Jimenez E, Perucha E, Warrens A, Lechler RI, Flavia R, Stevenson S, Milton R (2006). Advances in Immune Monitoring in Renal Transplantation. (Abstract #1888) World Transplant Congress, Boston, MA, July 22-27, 2006.
Validation of a Functional Assay of IgE-Facilitated CD23-Dependent Allergen Binding to B Cells to Monitor Clinical Effica
2006 AAAAI Annual Meeting, Miami, FL, March 3-7, 2006
Shamji MH, Wilcock LK, Larché M, Francis JN, Durham SR
Shamji MH, Wilcock LK, Larché M, Francis JN, Durham SR (2006). Validation of a Functional Assay of IgE-Facilitated CD23-Dependent Allergen Binding to B Cells to Monitor Clinical Effica. 2006 AAAAI Annual Meeting, Miami, FL, March 3-7, 2006.
Efficacy of Indirect pathway antigen processing and allorecognition
7th Trends in Immunosuppression, Berlin, Germany, February, 2006 (Abstract #918)
Stevenson S, Hernandez-Fuentes M, Lechler RI, Jiang S, Lombardi G, Barber L
Stevenson S, Hernandez-Fuentes M, Lechler RI, Jiang S, Lombardi G, Barber L (2006). Efficacy of Indirect pathway antigen processing and allorecognition. (Abstract #918) 7th Trends in Immunosuppression, Berlin, Germany, February, 2006.
Treatment of MS patients with TCR peptide vaccine
4th International Workshop on T-Cell Vaccination, Galillee, Israel, February, 2006
Vandenbark AA
Vandenbark AA (2006). Treatment of MS patients with TCR peptide vaccine. 4th International Workshop on T-Cell Vaccination, Galillee, Israel, February, 2006.
Induction of IL-10 Occurs Early and Precedes Serum IgG Blocking Activity During a Cluster Regimen of Grass Pollen Immuno
2006 AAAAI Annual Meeting, Miami, FL, March 3-7, 2006
Wilcock LK, Francis JN, Till SJ, Durham SR, Paraskavopoulos G
Wilcock LK, Francis JN, Till SJ, Durham SR, Paraskavopoulos G (2006). Induction of IL-10 Occurs Early and Precedes Serum IgG Blocking Activity During a Cluster Regimen of Grass Pollen Immuno. 2006 AAAAI Annual Meeting, Miami, FL, March 3-7, 2006.
Increased serum inhibitory activity for basophil histamine release corresponds with reductions in early skin responses i
British Society of Allergy and Clinical Immunology, Loughborough, UK, July, 2006
Wilcock LK, Francis JN, Aalberse RC, Till SJ, Durham SR, Paraskevopolous G, Stapel SO
Wilcock LK, Francis JN, Aalberse RC, Till SJ, Durham SR, Paraskevopolous G, Stapel SO (2006). Increased serum inhibitory activity for basophil histamine release corresponds with reductions in early skin responses i. British Society of Allergy and Clinical Immunology, Loughborough, UK, July, 2006.
Towards semantic interoperability in a clinical trials management system
Fifth International Seman-tic Web Conference (ISWC 2006), Athens, GA, Nov 5-9, 2006
Martins SB, Parrish D, Das AK, Shankar R, O’Connor MJ
Martins SB, Parrish D, Das AK, Shankar R, O’Connor MJ (2006). Towards semantic interoperability in a clinical trials management system. Fifth International Seman-tic Web Conference (ISWC 2006), Athens, GA, Nov 5-9, 2006.
A Knowledge-Based System for Managing Clinical Trials
19th IEEE International Symposium on Computer-Based Medical Systems, Salt Lake City, Utah, June 22-23, 2006
Shankar RD, Martins SB, O'Connor MJ, Parrish DB, Das AK
Shankar RD, Martins SB, O'Connor MJ, Parrish DB, Das AK (2006). A Knowledge-Based System for Managing Clinical Trials. 19th IEEE International Symposium on Computer-Based Medical Systems, Salt Lake City, Utah, June 22-23, 2006.
Epoch: an Ontological Framework to Support Clinical Trials Management
International Workshop on Health Information and Knowledge Management (HIKM 2006), Arlington, VA, Nov 11, 2006
Shankar RD, O'Connor MJ, Parrish DB, Martins SB, Das AK
Shankar RD, O'Connor MJ, Parrish DB, Martins SB, Das AK (2006). Epoch: an Ontological Framework to Support Clinical Trials Management. International Workshop on Health Information and Knowledge Management (HIKM 2006), Arlington, VA, Nov 11, 2006.
Comparison of RNA Preparation Methods and Their Effect on Cytokine/Chemokine Gene Expression
2005 Meeting of the Federation of Clinical Immunology Societies, Boston, MA, May 12-16, 2005 (Abstract #Su1.60)
Asare AL, Kolchinsky SA, Wood P, Seyfert-Margolis VL.
Asare AL, Kolchinsky SA, Wood P, Seyfert-Margolis VL. (2005). Comparison of RNA Preparation Methods and Their Effect on Cytokine/Chemokine Gene Expression. (Abstract #Su1.60) 2005 Meeting of the Federation of Clinical Immunology Societies, Boston, MA, May 12-16, 2005.
Precursor dendritic cell subsets in kidney allograft recipients after induction with alemtuzumab (C1H) vs Thymoglobulin
ASHI 31st Annual Meeting, Washington, DC, Oct 17-21, 2005
Carreno MR, Ciancio G, Burke GW, Cirocco R, Mathew J, Jin Y, Miller J, Salman F, Esquenazi V.
Carreno MR, Ciancio G, Burke GW, Cirocco R, Mathew J, Jin Y, Miller J, Salman F, Esquenazi V. (2005). Precursor dendritic cell subsets in kidney allograft recipients after induction with alemtuzumab (C1H) vs Thymoglobulin. ASHI 31st Annual Meeting, Washington, DC, Oct 17-21, 2005.
Careno-T regulatory cells after induction therapy with Campath-1H, vs Thymoglobulin vs Daclizumab in kidney transplant recipien
American Transplant Congress, Seattle, WA, May 21, 2005
Carreno M, Cirocco R, Mathew J, Ciancio G, Burke GW, Miller J, Esquenazi V.
Carreno M, Cirocco R, Mathew J, Ciancio G, Burke GW, Miller J, Esquenazi V. (2005). Careno-T regulatory cells after induction therapy with Campath-1H, vs Thymoglobulin vs Daclizumab in kidney transplant recipien. American Transplant Congress, Seattle, WA, May 21, 2005.
Casale-Omalizumab pretreatment prevents allergic reactions due to rush immunotherapy (RIT)
AAAAI Annual Meeting, San Antonio, TX, March 18-22, 2005 (Abstract #259)
Casale TB, Kline JN, Busse WW, Ballas ZK, Mokhtarani M, Seyfert-Margolis V, Bateman K, Moss MH, Townley RG.
Casale TB, Kline JN, Busse WW, Ballas ZK, Mokhtarani M, Seyfert-Margolis V, Bateman K, Moss MH, Townley RG. (2005). Casale-Omalizumab pretreatment prevents allergic reactions due to rush immunotherapy (RIT). (Abstract #259) AAAAI Annual Meeting, San Antonio, TX, March 18-22, 2005.
Cirocco-Increased production of the regulatory T-cell transcription factor Fox P-3m-RNA and CD4+CD25+ cells in Campath-1H and do
ASHI 31st Annual Meeting, Washington, DC, Oct 17-21, 2005
Cirocco R, Mathew J, Esquenazi V, Miller J., Careno M, Valone T
Cirocco R, Mathew J, Esquenazi V, Miller J., Careno M, Valone T (2005). Cirocco-Increased production of the regulatory T-cell transcription factor Fox P-3m-RNA and CD4+CD25+ cells in Campath-1H and do. ASHI 31st Annual Meeting, Washington, DC, Oct 17-21, 2005.
Collin-NUSE and RLE: Quality assessment of oligonucleotide microarray data to quantify systemic variation
2005 Meeting of the Federation of Clinical Immunology Societies, Boston, MA, May 12-16, 2005 (Abstract #Su2.110)
Asare AL, Kolchinsky SA, Seyfert-Margolis VL., Collin F, Speed TP
Asare AL, Kolchinsky SA, Seyfert-Margolis VL., Collin F, Speed TP (2005). Collin-NUSE and RLE: Quality assessment of oligonucleotide microarray data to quantify systemic variation. (Abstract #Su2.110) 2005 Meeting of the Federation of Clinical Immunology Societies, Boston, MA, May 12-16, 2005.
Garcia-Comparative chimerism levels in cadaver and living related donor whole bone marrow infused kidney recipients vs. a 2X ste
th Basic Science Symposium of the International Transplantation Society, La Baule, France, June 19-23, 2005
Esquenazi V, Kleiner G, Burke GW, Ciancio G, Ricordi C, Garcia-Morales RO, Cirocco RE, Carreno MR, Kenyon NS, Tzakis AG, Shariatmadar S, Miller J.
Esquenazi V, Kleiner G, Burke GW, Ciancio G, Ricordi C, Garcia-Morales RO, Cirocco RE, Carreno MR, Kenyon NS, Tzakis AG, Shariatmadar S, Miller J. (2005). Garcia-Comparative chimerism levels in cadaver and living related donor whole bone marrow infused kidney recipients vs. a 2X ste. th Basic Science Symposium of the International Transplantation Society, La Baule, France, June 19-23, 2005.
Hernandez0Immune Monitoring in Renal Transplantation
British Society of Immunology, Harrogate, UK, December, 2005
Hernandez-Fuentes MP, Sagoo P, Jimenez E, Rovis F, Stevenson S, Warrens A, Lechler R.
Hernandez-Fuentes MP, Sagoo P, Jimenez E, Rovis F, Stevenson S, Warrens A, Lechler R. (2005). Hernandez0Immune Monitoring in Renal Transplantation. British Society of Immunology, Harrogate, UK, December, 2005.
Kawai
American Transplant Congress, Seattle, WA, May 21, 2005 (Abstract #1535)
Kawai T, Sachs DH, Spitzer T, Tolkoff-Rubin N, Delmonico F, Saidman S, Shaffer J, Williams W, Dey B, McAfee S, Ko D, Hertl M, Goes N, Wong W, Fishman JA, Colvin RB, Sykes M, Cosimi B.
Kawai T, Sachs DH, Spitzer T, Tolkoff-Rubin N, Delmonico F, Saidman S, Shaffer J, Williams W, Dey B, McAfee S, Ko D, Hertl M, Goes N, Wong W, Fishman JA, Colvin RB, Sykes M, Cosimi B. (2005). Kawai. (Abstract #1535) American Transplant Congress, Seattle, WA, May 21, 2005.
Khoury-A Phase I Trial of CTLA4Ig Treatment in MS
57th Annual Meeting of the American Academy of Neurology, Miami Beach, FL, April 9-15, 2005 (Abstract #S46.004)
Khoury SJ, Viglietta V, Hafler D, Bourcier K, Buckle G, Guttmann C, Bikowski M, Rusche J, Landy H, McNally J, Jauregui K.
Khoury SJ, Viglietta V, Hafler D, Bourcier K, Buckle G, Guttmann C, Bikowski M, Rusche J, Landy H, McNally J, Jauregui K. (2005). Khoury-A Phase I Trial of CTLA4Ig Treatment in MS. (Abstract #S46.004) 57th Annual Meeting of the American Academy of Neurology, Miami Beach, FL, April 9-15, 2005.
Kline-Omalizumab Plus Rush Immunotherapy (RIT) Is More Effective Than RIT Alone In Preventing Ragweed-Induced Seasonal Allergic
61st Annual Meeting of the American Academy of Allergy, Asthma and Immunology, San Antonio, TX, March 18-22, 2005 (Abstract #827)
Kline JN, Casale TB, Busse WW, Ballas ZK, Mokhtarani M, Seyfert-Margolis V, Asare A, Bateman K, Moss MH, Bromstead C, Townley RG.
Kline JN, Casale TB, Busse WW, Ballas ZK, Mokhtarani M, Seyfert-Margolis V, Asare A, Bateman K, Moss MH, Bromstead C, Townley RG. (2005). Kline-Omalizumab Plus Rush Immunotherapy (RIT) Is More Effective Than RIT Alone In Preventing Ragweed-Induced Seasonal Allergic . (Abstract #827) 61st Annual Meeting of the American Academy of Allergy, Asthma and Immunology, San Antonio, TX, March 18-22, 2005.
Klunker-Ragweed immunotherapy serum inhibits facilitated allergen presentation
2005 Annual Meeting of the British Society for Allergy & Clinical Immunology, Loughborough, UK, July 18-20, 2005
Klunker S, Francis JN, Durham SR
Klunker S, Francis JN, Durham SR (2005). Klunker-Ragweed immunotherapy serum inhibits facilitated allergen presentation. 2005 Annual Meeting of the British Society for Allergy & Clinical Immunology, Loughborough, UK, July 18-20, 2005.
Liu-Immune monitoring: the effects of hOKT3γ1 (Ala-Ala) in a patient with new onset type 1 diabetes mellitus
Meeting of the Federation of Clinical Immunology Societies, Boston, MA, May 12-16, 2005 (Abstract #Su1.70)
Herold KC, Gitelman SE, Liu WH, Szot G, Earle KE, Masharani U, Bluestone JA.
Herold KC, Gitelman SE, Liu WH, Szot G, Earle KE, Masharani U, Bluestone JA. (2005). Liu-Immune monitoring: the effects of hOKT3γ1 (Ala-Ala) in a patient with new onset type 1 diabetes mellitus. (Abstract #Su1.70) Meeting of the Federation of Clinical Immunology Societies, Boston, MA, May 12-16, 2005.
Mathew-Regulatory cell development in an LRD-kidney transplant recipient treated with alemtuzumab and donor stem cell infusions
ASHI 31st Annual Meeting, Washington, DC, Oct 17-21, 2005
Vallone T, Carreno M, Rosen A, Gomez C, Garcia-Morales R, Blomberg B, Fuller L, Ciancio G, Esquenazi V, Miller J, Mathew JM, Burke G
Vallone T, Carreno M, Rosen A, Gomez C, Garcia-Morales R, Blomberg B, Fuller L, Ciancio G, Esquenazi V, Miller J, Mathew JM, Burke G (2005). Mathew-Regulatory cell development in an LRD-kidney transplant recipient treated with alemtuzumab and donor stem cell infusions . ASHI 31st Annual Meeting, Washington, DC, Oct 17-21, 2005.
Offner-Expression of the Treg cell associated Foxp3 gene is decreased in MS patients and increases following immunization with a
5th Meeting of the European Neurological Society, Vienna, Austria, June 18-22, 2005
Offner H, Huan J, Bartholomew R, Bourdette D, Vandenbark A.
Offner H, Huan J, Bartholomew R, Bourdette D, Vandenbark A. (2005). Offner-Expression of the Treg cell associated Foxp3 gene is decreased in MS patients and increases following immunization with a. 5th Meeting of the European Neurological Society, Vienna, Austria, June 18-22, 2005.
Paraskevop-Grass pollen injection immunotherapy: Time course of suppression of allergen-induced late-phase skin responses
J Allergy Clin Immunology, 115, S266, 2005
Paraskevopoulos G, Jacobson MR, Till SJ, Francis JN, Carr V, Calderon M, Durham SR.
Paraskevopoulos G, Jacobson MR, Till SJ, Francis JN, Carr V, Calderon M, Durham SR. (2005). Paraskevop-Grass pollen injection immunotherapy: Time course of suppression of allergen-induced late-phase skin responses. J Allergy Clin Immunology, 115, S266, 2005.
Raddassi-Effect of freezing/thawing conditions and their optimization for quality control of PBMC viability and functional assay
2005 Meeting of the Federation of Clinical Immunology Societies, Boston, MA, May 12-16, 2005 (Abstract #Su1.106)
Raddassi K, Bourcier K, Estevam J, Hafler DA, Seyfert-Margolis V.
Raddassi K, Bourcier K, Estevam J, Hafler DA, Seyfert-Margolis V. (2005). Raddassi-Effect of freezing/thawing conditions and their optimization for quality control of PBMC viability and functional assay. (Abstract #Su1.106) 2005 Meeting of the Federation of Clinical Immunology Societies, Boston, MA, May 12-16, 2005.
Shamji-Analytical validation of a novel flow cytometric-based Facilitated Allergen Presentation (FAP) assay as a tool for monito
2005 Annual Meeting of the British Society for Allergy & Clinical Immunology, Loughborough, UK, July 18-20, 2005
Larché M, Shamji M, Wilcock L, Durham S, Francis J.
Larché M, Shamji M, Wilcock L, Durham S, Francis J. (2005). Shamji-Analytical validation of a novel flow cytometric-based Facilitated Allergen Presentation (FAP) assay as a tool for monito. 2005 Annual Meeting of the British Society for Allergy & Clinical Immunology, Loughborough, UK, July 18-20, 2005.
Shamkar-A knowledge-driven approach to manage clinical trial protocols in the Immune Tolerance Network
American Medical Informatics Association Symposium, Unknown, October 25, 2005
Shankar R, O'Connor M, Martins S, Tu S, Parrish D, Musen M, Das A.
Shankar R, O'Connor M, Martins S, Tu S, Parrish D, Musen M, Das A. (2005). Shamkar-A knowledge-driven approach to manage clinical trial protocols in the Immune Tolerance Network. American Medical Informatics Association Symposium, Unknown, October 25, 2005.
Vandenbark-Decreased Foxp3 levels in MS patients are normalized by TCR peptide vaccination
19th National Congress of the Polish Neurological Society, Lodz, Poland, Aug 31-Sept 3, 2005
Huan J, Bartholomew R, Offner H, Vandenbark A, Bourdette D.
Huan J, Bartholomew R, Offner H, Vandenbark A, Bourdette D. (2005). Vandenbark-Decreased Foxp3 levels in MS patients are normalized by TCR peptide vaccination. 19th National Congress of the Polish Neurological Society, Lodz, Poland, Aug 31-Sept 3, 2005.
Vandenbark-TCR peptide vaccination in MS induces high levels of IL-10 and restores decreased Foxp3 levels
ECTRIMS/ACTRIMS, Thessaloniki, Greece, Sept 28-Oct 1, 2005
Vandenbark A, Huan J, Bartholomew R, Offner H, Bourdette D.
Vandenbark A, Huan J, Bartholomew R, Offner H, Bourdette D. (2005). Vandenbark-TCR peptide vaccination in MS induces high levels of IL-10 and restores decreased Foxp3 levels. ECTRIMS/ACTRIMS, Thessaloniki, Greece, Sept 28-Oct 1, 2005.
Wilcock0Time-course of serum IgG4 levels and IgG inhibitory activity following withdrawal of grass pollen immunotherapy (IT)
J Allergy Clin Immunology, 115, S265, 2005
Wilcock LK, Wachholz PA, Klunker S, Francis JN, Durham SR, Na D H, Larsen JN
Wilcock LK, Wachholz PA, Klunker S, Francis JN, Durham SR, Na D H, Larsen JN (2005). Wilcock0Time-course of serum IgG4 levels and IgG inhibitory activity following withdrawal of grass pollen immunotherapy (IT). J Allergy Clin Immunology, 115, S265, 2005.
BrooksWorrell-Marked Differences in T Cell Reactivity in Recently Diagnosed Type 1 Diabetes Patients Versus Controls
XXIIth International Congress of Immunology, Montreal, Canada, July 18-23, 2004 (Abstract #2778)
Dosch HM, Seyfert V, Greenbaum CJ, Gitelman SE, Palmer JP, Brooks-Worrell BM, Herold K
Dosch HM, Seyfert V, Greenbaum CJ, Gitelman SE, Palmer JP, Brooks-Worrell BM, Herold K (2004). BrooksWorrell-Marked Differences in T Cell Reactivity in Recently Diagnosed Type 1 Diabetes Patients Versus Controls. (Abstract #2778) XXIIth International Congress of Immunology, Montreal, Canada, July 18-23, 2004.
Casale-Anti-IgE monoclonal antibody administered with immunotherapy
American College of Allergy, Asthma and Immunology (ACAAI), Boston, MA, Nov 4-9, 2004
Casale TB
Casale TB (2004). Casale-Anti-IgE monoclonal antibody administered with immunotherapy. American College of Allergy, Asthma and Immunology (ACAAI), Boston, MA, Nov 4-9, 2004.
Casale-Omalizumab And Immunotherapy
American College of Allergy, Asthma and Immunology (ACAAI), Boston, MA, Nov 4-9, 2004
Casale TB
Casale TB (2004). Casale-Omalizumab And Immunotherapy. American College of Allergy, Asthma and Immunology (ACAAI), Boston, MA, Nov 4-9, 2004.
Eisenbarth-Autoantibodies in type 1 diabetes and neurological disorders.
XXIIth International Congress of Immunology, Montreal, Canada, July 18-23, 2004
Eisenbarthh GS
Eisenbarthh GS (2004). Eisenbarth-Autoantibodies in type 1 diabetes and neurological disorders.. XXIIth International Congress of Immunology, Montreal, Canada, July 18-23, 2004.
Fudaba-Alloresponses in tolerant recipients of combined kidney/bone marrow transplantation with non-myeloablative conditioning
International Congress of Transplantation, Vienna, Austria, Sept 5-10, 2004 (Abstract #P931)
Fudaba Y, Shaffer JM, Kraus A, Cosimi AB, Delmonico FL, Dey B, Kawai T, McAfee S, Preffer F, Tolkoff-Rubin N, Sachs DH, Saidman Sl, Spitzer TR, Sykes M
Fudaba Y, Shaffer JM, Kraus A, Cosimi AB, Delmonico FL, Dey B, Kawai T, McAfee S, Preffer F, Tolkoff-Rubin N, Sachs DH, Saidman Sl, Spitzer TR, Sykes M (2004). Fudaba-Alloresponses in tolerant recipients of combined kidney/bone marrow transplantation with non-myeloablative conditioning. (Abstract #P931) International Congress of Transplantation, Vienna, Austria, Sept 5-10, 2004.
Herold-Treatment with hOKT3γ1(Ala-Ala) improves insulin responses and reduces insulin requirements in patients with new onset Ty
XXIIth International Congress of Immunology, Montreal, Canada, July 18-23, 2004 (Abstract #1885)
Herold K, Gitelman S, Masharani U, Greenbaum C, Hagopian W, Gottlieb P, Muir A, Ramos E, Bluestone JA, Tomlin N
Herold K, Gitelman S, Masharani U, Greenbaum C, Hagopian W, Gottlieb P, Muir A, Ramos E, Bluestone JA, Tomlin N (2004). Herold-Treatment with hOKT3γ1(Ala-Ala) improves insulin responses and reduces insulin requirements in patients with new onset Ty. (Abstract #1885) XXIIth International Congress of Immunology, Montreal, Canada, July 18-23, 2004.
Herold-ADA-Treatment with hOKT3γ1(Ala-Ala) improves insulin responses and reduces insulin requirements in patients with new onse
64th Scientific Sessions of the American Diabetes Association, Orlando, FL, June 4-8, 2004 (Abstract #271-OR)
Herold K, Gitelman S, Masharani U, Greenbaum C, Hagopian W, Gottlieb P, Ramos E, Bluestone JA, Muir A, Tomilin N
Herold K, Gitelman S, Masharani U, Greenbaum C, Hagopian W, Gottlieb P, Ramos E, Bluestone JA, Muir A, Tomilin N (2004). Herold-ADA-Treatment with hOKT3γ1(Ala-Ala) improves insulin responses and reduces insulin requirements in patients with new onse. (Abstract #271-OR) 64th Scientific Sessions of the American Diabetes Association, Orlando, FL, June 4-8, 2004.
Kawai-20040Combined kidney and bone marrow transplantation for induction of mixed chimerism and renal allograft tolerance in HLA
American Transplant Congress, Boston, MA, May 14-19, 2004 (Abstract #1217)
Kawai T, Sachs DH, Spitzer T, Sykes M, Tolkoff-Rubin N, Delmonico F, Saidman S, Shaffer J, Dey B, McAfee S, Williams W, Ko D, Hertl M, Goes N, Wong W, Colvin RB, Cosimi AB
Kawai T, Sachs DH, Spitzer T, Sykes M, Tolkoff-Rubin N, Delmonico F, Saidman S, Shaffer J, Dey B, McAfee S, Williams W, Ko D, Hertl M, Goes N, Wong W, Colvin RB, Cosimi AB (2004). Kawai-20040Combined kidney and bone marrow transplantation for induction of mixed chimerism and renal allograft tolerance in HLA. (Abstract #1217) American Transplant Congress, Boston, MA, May 14-19, 2004.
Kawai0Combined kidney and bone marrow transplantation for induction of mixed chimerism and renal allograft tolerance in HLA mism
20th International Congress of the Transplantation Society, Vienna, Austria, September 5-10, 2004 (Abstract #O112)
Kawai T, Sachs DH, Spitzer T, Sykes M, Tolkoff-Rubin N, Delmonico F, Saidman S, Shaffer J, Dey B, McAfee S, Ko D, Wong W, Williams W, Goes N, Hertl M, Smith RN, Colvin RB, Cosimi AB
Kawai T, Sachs DH, Spitzer T, Sykes M, Tolkoff-Rubin N, Delmonico F, Saidman S, Shaffer J, Dey B, McAfee S, Ko D, Wong W, Williams W, Goes N, Hertl M, Smith RN, Colvin RB, Cosimi AB (2004). Kawai0Combined kidney and bone marrow transplantation for induction of mixed chimerism and renal allograft tolerance in HLA mism. (Abstract #O112) 20th International Congress of the Transplantation Society, Vienna, Austria, September 5-10, 2004.
Khoury-Phase I trial of CTLA4Ig treatment in MS.
56th American Academy of Neurology, San Francisco, CA, Aprli 24 - May 1, 2004 (Abstract #S12.003)
Khoury SJ, Bourcier K, Buckle G, Bikowski M, Guttmann C, Rioux P, Jauregui K
Khoury SJ, Bourcier K, Buckle G, Bikowski M, Guttmann C, Rioux P, Jauregui K (2004). Khoury-Phase I trial of CTLA4Ig treatment in MS.. (Abstract #S12.003) 56th American Academy of Neurology, San Francisco, CA, Aprli 24 - May 1, 2004.
Lakey-Standardization of Human Islet Isolation for a Multi-Center Transplant Trial.
20th International Congress of the Transplantation Society, Vienna, Austria, September 5-10, 2004 (Abstract #P432)
Lakey JRT, Ricordi C, Hering B, DiMercurio B, Lindblad R, Olack B, Reems JA, Ansite J, Brandhorst H, Bertuzzi F, Berney T, Close N, Shapiro AMJ, Vivano L, O’Neil J
Lakey JRT, Ricordi C, Hering B, DiMercurio B, Lindblad R, Olack B, Reems JA, Ansite J, Brandhorst H, Bertuzzi F, Berney T, Close N, Shapiro AMJ, Vivano L, O’Neil J (2004). Lakey-Standardization of Human Islet Isolation for a Multi-Center Transplant Trial.. (Abstract #P432) 20th International Congress of the Transplantation Society, Vienna, Austria, September 5-10, 2004.
Lakey-ADA-Standardization of human islet isolation procedures for a multicenter transplant trial.
64th Scientific Sessions of the American Diabetes Association, Orlando, FL, June 4-8, 2004
Lakey JRT, Ricordi C, DiMercurio B, Lindblad R, Olack B, Reems JA, Ansite J, Bertuzzi F, Berney T, Viviano L, O'Neil J, Close N, Shapiro AMJ, Herring B, Brandhorst D
Lakey JRT, Ricordi C, DiMercurio B, Lindblad R, Olack B, Reems JA, Ansite J, Bertuzzi F, Berney T, Viviano L, O'Neil J, Close N, Shapiro AMJ, Herring B, Brandhorst D (2004). Lakey-ADA-Standardization of human islet isolation procedures for a multicenter transplant trial.. 64th Scientific Sessions of the American Diabetes Association, Orlando, FL, June 4-8, 2004.
Mazariegos-Immunologic Assays in Patients Successfully Withdrawn from Immunosuppression (IS) after Liver Transplantation
American Transplant Congress, Boston, MA, May 14-19, 2004 (Abstract #521)
Mazariegos GV, Zahorchak A, Reyes J, Zeevi A, Chapman H, Girnita A, McDade K, Thompson A
Mazariegos GV, Zahorchak A, Reyes J, Zeevi A, Chapman H, Girnita A, McDade K, Thompson A (2004). Mazariegos-Immunologic Assays in Patients Successfully Withdrawn from Immunosuppression (IS) after Liver Transplantation. (Abstract #521) American Transplant Congress, Boston, MA, May 14-19, 2004.
Parrish-Applying standard data warehousing approaches to biomedical data
BECON/BISTIC 2004 SYMPOSIUM - Biomedical Informatics for Clinical Decision Support: A Vision for the 21st Century, Bethesda, MD, June 21-22, 2004
Parrish D, Raab M
Parrish D, Raab M (2004). Parrish-Applying standard data warehousing approaches to biomedical data. BECON/BISTIC 2004 SYMPOSIUM - Biomedical Informatics for Clinical Decision Support: A Vision for the 21st Century, Bethesda, MD, June 21-22, 2004.
Shaffer-Mechanisms of donor-specific unresponsiveness in tolerant recipient of combined non-myeloablative HLA-mismatched bone ma
American Transplant Congress, Boston, MA, May 14-19, 2004 (Abstract #526)
Shaffer JM, Kawai T, Fudaba Y, Cosimi AB, Saidman S, Preffer F, Delmonico F, McAfee S, Dey B, Spitzer TR, Sachs DH, Sykes M, Dombkowski D, Rubin-Tolkoff N
Shaffer JM, Kawai T, Fudaba Y, Cosimi AB, Saidman S, Preffer F, Delmonico F, McAfee S, Dey B, Spitzer TR, Sachs DH, Sykes M, Dombkowski D, Rubin-Tolkoff N (2004). Shaffer-Mechanisms of donor-specific unresponsiveness in tolerant recipient of combined non-myeloablative HLA-mismatched bone ma. (Abstract #526) American Transplant Congress, Boston, MA, May 14-19, 2004.
Shaffer-ICOT-Mechanisms of Donor-Specific Unresponsiveness in Tolerant Recipients of Combined Non-Myeloablative HLA-Mismatched
20th International Congress of the Transplantation Society, Vienna, Austria, September 5-10, 2004 (Abstract #O36)
Shaffer J, Kawai T, Cosimi AB, Fudaba Y, Saidman S, Preffer F, Dombkowski D, Delmonico F, McAfee S, Tolkoff-Rubin N, Ballen K, Dey B, Spitzer TR, Sachs DH, Sykes M
Shaffer J, Kawai T, Cosimi AB, Fudaba Y, Saidman S, Preffer F, Dombkowski D, Delmonico F, McAfee S, Tolkoff-Rubin N, Ballen K, Dey B, Spitzer TR, Sachs DH, Sykes M (2004). Shaffer-ICOT-Mechanisms of Donor-Specific Unresponsiveness in Tolerant Recipients of Combined Non-Myeloablative HLA-Mismatched. (Abstract #O36) 20th International Congress of the Transplantation Society, Vienna, Austria, September 5-10, 2004.
Shapiro-International Multi-Center Trial of Islet Transplantation Using the Edmonton Protocol in Patients with Type 1 Diabetes
20th International Congress of the Transplantation Society, Vienna, Austria, September 5-10, 2004 (Abstract #O449)
Shapiro AMJ, Ricordi C, Hering B, DiMercurio B, Lindblad R, Alejandro R, Cagliero E, Berney T, Secchi A, Brennan D, E, Viviano L, Ryan E, Lakey J, Brendal M, Robertson P, Ramos, Close N
Shapiro AMJ, Ricordi C, Hering B, DiMercurio B, Lindblad R, Alejandro R, Cagliero E, Berney T, Secchi A, Brennan D, E, Viviano L, Ryan E, Lakey J, Brendal M, Robertson P, Ramos, Close N (2004). Shapiro-International Multi-Center Trial of Islet Transplantation Using the Edmonton Protocol in Patients with Type 1 Diabetes. (Abstract #O449) 20th International Congress of the Transplantation Society, Vienna, Austria, September 5-10, 2004.
Shapiro-ADA-International multi-center trial of islet transplantation using the Edmonton Protocol in patients with Type 1 diabet
64th Scientific Sessions of the American Diabetes Association, Orlando, FL, June 4-8, 2004 (Abstract #1904-P)
Shapiro J, Ricordi C, Hering B, DiMercurio B, Lindblad R, Alejandro R, Cagliero E, Brendel M, Robertson P, Berney T, Secchi A, Brennan D, Ramos E, Viviano L, Ryan E, Close N, Lakey J
Shapiro J, Ricordi C, Hering B, DiMercurio B, Lindblad R, Alejandro R, Cagliero E, Brendel M, Robertson P, Berney T, Secchi A, Brennan D, Ramos E, Viviano L, Ryan E, Close N, Lakey J (2004). Shapiro-ADA-International multi-center trial of islet transplantation using the Edmonton Protocol in patients with Type 1 diabet. (Abstract #1904-P) 64th Scientific Sessions of the American Diabetes Association, Orlando, FL, June 4-8, 2004.